In the last six days, multiple White House experts have all emphasized they don’t support the use of hydroxychloroquine as a treatment option for COVID-19. 

Differentiating between actual signs of a COVID-19 infection and standard cardiac complications can be especially difficult.

In 1982, LAPD Police Chief Darryl Gates called the cardiologist with an unexpected question. 

The American College of Cardiology, Society of Thoracic Surgeons, American Association for Thoracic Surgery and Society for Cardiovascular Angiography and Interventions all collaborated on the response. 

Overall, the PCSK9 inhibitor was associated with a steady increase in coronary artery area and “significant coronary blood flow improvement.”

Hydroxychloroquine was once just an ordinary antimalarial medication—and then 2020 and COVID-19 happened. So how did we get here? 

In this modern era of healthcare where value trumps volume, assessing a physician’s performance is more important than ever.

Researchers tracked data related to more than 178 million U.S. residents. Their findings could help with the development of public policies going forward.

Consolidation has been a major theme for healthcare providers in recent years, with larger practices continuing to thrive compared to their smaller counterparts. But what about cardiology specifically? 

Nearly 600 hospitals were considered for this updated ranking.